Skip to main content

Table 1 Baseline characteristics of patients with BCP-ALL (N = 164)

From: FPGS rs1544105 polymorphism is associated with treatment outcome in pediatric B-cell precursor acute lymphoblastic leukemia

Characteristics N (%)
Age (yr), median (range) 4
<1 0
1-9 136 (82.9)
≥10 28 (17.1)
Gender  
Male 104 (63.4)
Female 60 (36.6)
WBC (109/L)  
<50 136 (82.9)
≥50 28 (17.1)
Treatment group  
SR 62 (37.8)
MR 81 (49.4)
HR 21 (12.8)
Fusion genes  
TEL-AML1 41 (25.0)
E2A-PBX1 16 (9.8)
BCR-ABL 8 (4.9)
MLL-AF4 1 (0.6)
CNS involvement 2 (1.2)
Event  
Relapse 16 (9.8)
Isolated BM 13 (7.9)
Isolated CNS 1 (0.6)
Isolated testis 2 (1.2)
Death* 4 (2.4)
Prednisone response  
Good 162 (98.8)
Poor 2 (1.2)
  1. BCP-ALL, B-cell precursor ALL; WBC, white blood cell count; SR, standard-risk; MR, medium-risk; HR, high-risk; BM, bone marrow; CNS, central nervous system. *4 patients died of severe infections during induction.
\